
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Histone Deacetylase 3‐Directed PROTACs Have Anti‐inflammatory Potential by Blocking Polarization of M0‐like into M1‐like Macrophages
Chunlong Zhao, Shipeng Chen, Deng Chen, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 42
Open Access | Times Cited: 8
Chunlong Zhao, Shipeng Chen, Deng Chen, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 42
Open Access | Times Cited: 8
Showing 8 citing articles:
Discovery of a potential hematologic malignancies therapy: Selective and potent HDAC7 PROTAC degrader targeting non-enzymatic function
Yuheng Jin, Xuxin Qi, Xiaoli Yu, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Yuheng Jin, Xuxin Qi, Xiaoli Yu, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Exploration and Identification of Potential Biomarkers and Immune Cell Infiltration Analysis in Synovial Tissue of Rheumatoid Arthritis
Yi Zhao, Huifang Hu, Tao Chen, et al.
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 2
Closed Access
Yi Zhao, Huifang Hu, Tao Chen, et al.
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 2
Closed Access
Development of Ethyl-Hydrazide-Based Selective Histone Deacetylase 6 (HDAC6) PROTACs
Daniel Stopper, Irina Honin, Felix Feller, et al.
ACS Medicinal Chemistry Letters (2025)
Closed Access
Daniel Stopper, Irina Honin, Felix Feller, et al.
ACS Medicinal Chemistry Letters (2025)
Closed Access
PROTAC‐Mediated HDAC7 Protein Degradation Unveils Its Deacetylase‐Independent Proinflammatory Function in Macrophages
Kailibinuer Kadier, Tian Niu, Baoli Ding, et al.
Advanced Science (2024)
Open Access | Times Cited: 2
Kailibinuer Kadier, Tian Niu, Baoli Ding, et al.
Advanced Science (2024)
Open Access | Times Cited: 2
Impact of HDAC inhibitors on macrophage polarization to enhance innate immunity against infections
M Bhat, Sonja Srdanović, Lotta‐Riina Sundberg, et al.
Drug Discovery Today (2024), pp. 104193-104193
Open Access | Times Cited: 2
M Bhat, Sonja Srdanović, Lotta‐Riina Sundberg, et al.
Drug Discovery Today (2024), pp. 104193-104193
Open Access | Times Cited: 2
M1/M2 macrophage-targeted nanotechnology and PROTAC for the treatment of atherosclerosis
Yupeng Ma, Xiaofan Yang, Ke Ning, et al.
Life Sciences (2024) Vol. 352, pp. 122811-122811
Open Access | Times Cited: 1
Yupeng Ma, Xiaofan Yang, Ke Ning, et al.
Life Sciences (2024) Vol. 352, pp. 122811-122811
Open Access | Times Cited: 1
Cereblon-recruiting proteolysis targeting chimeras (PROTACs) can determine the selective degradation of HDAC1 over HDAC3
Aline Renata Pavan, Joshua P. Smalley, Urvashi Patel, et al.
Chemical Communications (2024)
Open Access
Aline Renata Pavan, Joshua P. Smalley, Urvashi Patel, et al.
Chemical Communications (2024)
Open Access
Bifidobacterium longum Metabolite Indole-3-Carboxaldehyde Blocks HDAC3 and Inhibits Macrophage NLRP3 Inflammasome Activation in Intestinal Ischemia/Reperfusion Injury
Yan Miao, Mian Wang, Hao Sun, et al.
Inflammation (2024)
Closed Access
Yan Miao, Mian Wang, Hao Sun, et al.
Inflammation (2024)
Closed Access